Skip to content
EN
DE
*protected email*
+49 211 942 522 98
Toggle Navigation
About us
Technology
Pipeline
Working with us
Partnering & Investing
Careers
Media
News & Events
Press
Philipp.Buerling
Categories
News, Press Release
New Alzheimer’s drug PRI-002 receives EMA approval for Phase II study
Continue reading
News
Priavoid selected to German Accelerator Program
Continue reading
Event
Prion 2022, Göttingen, 13-16 September
Continue reading
Event
Bio International, San Diego, 13-16 June
Continue reading
Event
Neuro4D, Mainz, 16-17 May
Continue reading
News, Press Release
Priavoid and Research Center Jülich receive funding from The Michael J. Fox Foundation
Continue reading
1
2
Next